Asia Pacific Rapid Acting Insulin Market Size Report, 2027

Asia Pacific Rapid Acting Insulin Market By Product Type (Insulin Lispro, Insulin Aspart and Insulin Glulisine), By Indication (Type 2 Diabetes and Type 1 Diabetes), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Providers), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

Published Date: May-2021 | Number of Pages: 90 | Format: PDF | Report ID: KBV-14824

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


TABLE 1 Asia Pacific Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Rapid Acting Insulin Market]
TABLE 4 Product Launches And Product Expansions– Rapid Acting Insulin Market
TABLE 5 Acquisition and Mergers– Rapid Acting Insulin Market
TABLE 6 Approvals and Trials– Rapid Acting Insulin Market
TABLE 7 Asia Pacific Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 8 Asia Pacific Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 9 Asia Pacific Insulin Lispro Market by Country, 2017 - 2020, USD Million
TABLE 10 Asia Pacific Insulin Lispro Market by Country, 2021 - 2027, USD Million
TABLE 11 Asia Pacific Insulin Aspart Market by Country, 2017 - 2020, USD Million
TABLE 12 Asia Pacific Insulin Aspart Market by Country, 2021 - 2027, USD Million
TABLE 13 Asia Pacific Insulin Glulisine Market by Country, 2017 - 2020, USD Million
TABLE 14 Asia Pacific Insulin Glulisine Market by Country, 2021 - 2027, USD Million
TABLE 15 Asia Pacific Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 16 Asia Pacific Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 17 Asia Pacific Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 18 Asia Pacific Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 19 Asia Pacific Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 20 Asia Pacific Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 21 Asia Pacific Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 22 Asia Pacific Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 23 Asia Pacific Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 24 Asia Pacific Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 25 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 26 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 27 Asia Pacific Online Providers Market by Country, 2017 - 2020, USD Million
TABLE 28 Asia Pacific Online Providers Market by Country, 2021 - 2027, USD Million
TABLE 29 Asia Pacific Rapid Acting Insulin Market by Country, 2017 - 2020, USD Million
TABLE 30 Asia Pacific Rapid Acting Insulin Market by Country, 2021 - 2027, USD Million
TABLE 31 China Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 32 China Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 33 China Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 34 China Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 35 China Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 36 China Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 37 China Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 38 China Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 39 Japan Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 40 Japan Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 41 Japan Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 42 Japan Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 43 Japan Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 44 Japan Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 45 Japan Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 46 Japan Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 47 India Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 48 India Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 49 India Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 50 India Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 51 India Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 52 India Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 53 India Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 54 India Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 55 South Korea Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 56 South Korea Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 57 South Korea Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 58 South Korea Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 59 South Korea Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 60 South Korea Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 61 South Korea Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 62 South Korea Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 63 Singapore Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 64 Singapore Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 65 Singapore Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 66 Singapore Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 67 Singapore Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 68 Singapore Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 69 Singapore Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 70 Singapore Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 71 Malaysia Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 72 Malaysia Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 73 Malaysia Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 74 Malaysia Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 75 Malaysia Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 76 Malaysia Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 77 Malaysia Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 78 Malaysia Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 79 Rest of Asia Pacific Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 80 Rest of Asia Pacific Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 81 Rest of Asia Pacific Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 82 Rest of Asia Pacific Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 83 Rest of Asia Pacific Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 84 Rest of Asia Pacific Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 85 Rest of Asia Pacific Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 86 Rest of Asia Pacific Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 87 key information - Merck & Co., Inc.
TABLE 88 Key Information – Sanofi S.A.
TABLE 89 Key information – Novo Nordisk A/S
TABLE 90 Key Information – Eli Lilly and Company
TABLE 91 key information – Adocia SA
TABLE 92 Key Information – Biocon Limited
TABLE 93 Key Information – Gan & Lee Pharmaceuticals
TABLE 94 key Information – Geropharm LLC
TABLE 95 Key Information – Wockhardt Ltd.
TABLE 96 Key Information – MannKind Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Recent strategies and developments: Novo Nordisk A/S
FIG 5 Recent strategies and developments: Eli Lilly and Company
FIG 6 Recent strategies and developments: MannKind Corporation

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities